ArticleDiabetes, obesity & metabolism2026

BALLAST study: A multicentre, open-label, randomized-controlled, 52-week clinical trial of the efficacy and safety of luseogliflozin in older Japanese adults with type 2 diabetes receiving leucine-enriched amino acid supplementation and physical exercise programme.

Yoshihiro Takahashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.